EudraVigilance training and support

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - December 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 8 December 2025, 09:00 (CET) to 10 December 2025, 13:00 (CET)

Virtual live hands-on training course for clinical trials sponsors using EudraVigilance system - October 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, from 1 October 2025, 14:00 (CEST) to 3 October 2025, 18:00 (CEST)

Human medicines European public assessment report (EPAR): Amlodipine / Valsartan Mylan, amlodipine,valsartan, Date of authorisation: 22/03/2016, Revision: 16, Status: Authorised

Human medicines European public assessment report (EPAR): Colobreathe, colistimethate sodium, Date of authorisation: 13/02/2012, Revision: 19, Status: Authorised

Summary of opinion: Cabometyx, 19/06/2025 Positive

Human medicines European public assessment report (EPAR): Ogsiveo, nirogacestat, Status: Opinion

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 June 2025

Human medicines European public assessment report (EPAR): Afiveg, aflibercept, Status: Opinion

Human medicines European public assessment report (EPAR): Eiyzey, aflibercept, Status: Opinion